Juewan Kim

Juewan Kim is a distinguished Senior Lead Scientist in Immunology at Vivodyne, with prior experience as Project Lead in the Oncology Strategy Unit at Daewoong Pharmaceuticals, where Juewan drove peptide cancer vaccine and synthetic lethality programs from early discovery to IND-enabling work. At Aimed Bio Inc., Juewan advanced oncology, immune-oncology, and immunology mAb and ADC programs as a Senior Scientist, leading assay development and compound nomination efforts. Earlier, as a Postdoctoral Researcher at the University of Adelaide, Juewan focused on generating stable human induced regulatory T cells while mentoring graduate students. Juewan holds a PhD in Immunology and a Bachelor of Science in Biotechnology from the University of Adelaide.